These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29700904)

  • 1. Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance "lock-in" program.
    Naumann RB; Marshall SW; Gottfredson NC; Lund JL; Ringwalt CL; Skinner AC
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):16-24. PubMed ID: 29700904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries.
    Naumann RB; Marshall SW; Lund JL; Gottfredson NC; Ringwalt CL; Skinner AC
    Drug Alcohol Depend; 2018 Jan; 182():112-119. PubMed ID: 29150151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.
    Hartung DM; Ahmed SM; Middleton L; Van Otterloo J; Zhang K; Keast S; Kim H; Johnston K; Deyo RA
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1053-1060. PubMed ID: 28722211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk.
    Naumann RB; Roberts AW; Marshall SW; Skinner AC
    Med Care; 2019 Mar; 57(3):213-217. PubMed ID: 30629016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lock-in loophole: Using mixed methods to explain patient circumvention of a Medicaid opioid restriction program.
    Roberts AW; Skinner AC; Lauffenburger JC; Galt KA
    Subst Abus; 2020; 41(4):510-518. PubMed ID: 31644398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse Policy.
    Roberts AW; Farley JF; Holmes GM; Oramasionwu CU; Ringwalt C; Sleath B; Skinner AC
    Health Aff (Millwood); 2016 Oct; 35(10):1884-1892. PubMed ID: 27702963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms.
    Rough K; Huybrechts KF; Hernandez-Diaz S; Desai RJ; Patorno E; Bateman BT
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):62-69. PubMed ID: 29687539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing Opioid Misuse: Evaluation of a Medicaid Controlled Substance Lock-In Program.
    Skinner AC; Ringwalt C; Naumann RB; Roberts AW; Moss LA; Sachdeva N; Weaver MA; Farley J
    J Pain; 2016 Nov; 17(11):1150-1155. PubMed ID: 27497767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Prescribing in the 2016 Medicare Fee-for-Service Population.
    Maciejewski ML; Zepel L; Hale SL; Wang V; Diamantidis CJ; Blaz JW; Olin S; Wilson-Frederick SM; James CV; Smith VA
    J Am Geriatr Soc; 2021 Feb; 69(2):485-493. PubMed ID: 33216957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Utilization and Comorbidity History of North Carolina Medicaid Beneficiaries in a Controlled Substance "Lock-in" Program.
    Naumann RB; Marshall SW; Lund JL; Skinner AC; Ringwalt C; Gottfredson NC
    N C Med J; 2019; 80(3):135-142. PubMed ID: 31072939
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion to Persistent or High-Risk Opioid Use After a New Prescription From the Emergency Department: Evidence From Washington Medicaid Beneficiaries.
    Meisel ZF; Lupulescu-Mann N; Charlesworth CJ; Kim H; Sun BC
    Ann Emerg Med; 2019 Nov; 74(5):611-621. PubMed ID: 31229392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of a Medicaid "lock-in" program on opioid use disorder treatment and services and naloxone dispensing.
    Naumann RB; Austin AE; Wang L; Roberts AW
    Drug Alcohol Depend; 2022 Apr; 233():109385. PubMed ID: 35276627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug monitoring and dispensing of prescription opioids.
    Brady JE; Wunsch H; DiMaggio C; Lang BH; Giglio J; Li G
    Public Health Rep; 2014; 129(2):139-47. PubMed ID: 24587548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the present state and potential of Medicaid controlled substance lock-in programs.
    Roberts AW; Skinner AC
    J Manag Care Spec Pharm; 2014 May; 20(5):439-46c. PubMed ID: 24761815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
    Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
    J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J; Abraham AJ; Perri M
    J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities across provider specialties in opioid prescriptions dispensed to medicaid beneficiaries with chronic noncancer pain.
    Ringwalt C; Roberts AW; Gugelmann H; Skinner AC
    Pain Med; 2015 Apr; 16(4):633-40. PubMed ID: 25287703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.